Orchard Therapeutics Outlines Differentiated Profile of Its HSC Gene Therapy Approach and Discusses Potential Future Applications at Virtual R&D Investor Event September 14, 2021
Proximie Selects 8×8 Call and Video Quality Performance Monitoring to Enhance Future of Surgical Healthcare September 14, 2021
Adaptimmune Announces Clinical Responses across Five Solid Tumor Indications with an Overall Response Rate of 36% and Promising Early Durability from its Next-Generation SURPASS Trial September 13, 2021
Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALS September 9, 2021
Precision BioSciences and iECURE Announce License and Collaboration Agreement to Develop ARCUS-Based Gene Editing Therapies September 9, 2021
Huadong Medicine and Insilico Medicine enter co-development partnership to advance oncology drug discovery by hitting undruggable targets September 8, 2021
Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment of Neurologic and Neuro-oncologic Diseases supported by Multi-Year Manufacturing Agreement with Lonza Group September 8, 2021
SoulBeing Joins Buoy Health’s Marketplace to Offer Alternative Medicine Services to Consumers September 7, 2021